- No file added yet -

Retrospective Chart Review on Real-World Use of Latanoprostene Bunod 0.024% in Treatment-Naïve Patients With Open-Angle Glaucoma

media

posted on 2020-09-24, 08:22 authored by Constance O. Okeke, Eitan S. Burstein, Valerie Trubnik, James E. Deom, Michael S. Cooper, Desirae A. Brinkley, J. James Thimons, Alexander J. Kabiri, Kerry M. Gelb

The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).